Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B

Overview of attention for article published in Patient preference and adherence, August 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Method of purifying glycosylated protein from host cell galectins and other contaminants

Grant US-11358983-B2

United States of America

Factor IX polypeptides and methods of use thereof

Grant US-10898554-B1

United States of America

Factor IX polypeptides and methods of use thereof

Grant US-10568943-B2

United States of America

Factor IX polypeptides and methods of use thereof

Grant US-10561714-B2

United States of America

Factor IX polypeptides and methods of use thereof

Grant US-10548954-B2

United States of America